Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 +0.12 (25.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $0.00 | |||
| Open | $0.51 | 52 Week Low | $0.00 | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $0.00 | |||
| Volume | 43,601,128 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 +0.12 (25.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $0.00 | |||
| Open | $0.51 | 52 Week Low | $0.00 | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $0.00 | |||
| Volume | 43,601,128 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 +0.12 (25.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $0.00 | |||
| Open | $0.51 | 52 Week Low | $0.00 | |||
| Day High | $0.68 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $0.00 | |||
| Volume | 43,601,128 | |||||



